Here’s how an unapproved drug like remdesivir, used in COVID-19 treatments, is legal, even if it’s unapproved by the FDA with unknown results.
Remdesivir, the first possible scientifically proven treatment for battling COVID-19, will become available for U.S. hospitals in the coming week, says the CEO of the biotech company producing the drug.
Daniel O’Day, CEO and chairman of Gilead Sciences, provided the update Sunday on the CBS News program “Face the Nation.” He said that the Foster City, California-headquartered company had donated 1.5 million vials to the U.S. government, enough to treat 150,000 to 200,000 patients.
Federal health officials will outlay the drug “based on things like ICU beds, where the course of the epidemic is in the United States,” O’Day said. “They will begin shipping tens of thousands of treatment courses out early this week and be adjusting that as the epidemic shifts and evolves in different cities.”
» Subscribe to USA TODAY: http://bit.ly/1xa3XAh
» Watch more on this and other topics from USA TODAY: https://bit.ly/2J1xQDh
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.